Primary Site >> Liver Cancer
Gene >> CYP3A7
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Selective induction of the CYP3A family by endosulfan and DNA-adduct formation in different hepatic and hepatoma cells. PMID: 21781690 |
Ref: Identification and characterization of genes associated with human hepatocellular carcinogenesis. PMID: 10519413 |
Ref: Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43. PMID: 12679136 |
Ref: Cytochrome P450 gene polymorphism and cancer. PMID: 15180491 |
Ref: Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma. PMID: 16077914 |
Ref: Whole-cell biotransformation assay for investigation of the human drug metabolizing enzyme CYP3A7. PMID: 20637317 |
Ref: Expression of P450 and nuclear receptors in normal and end-stage Chinese livers. PMID: 25024626 Ref: Dual-color fluorescence imaging to monitor CYP3A4 and CYP3A7 expression in human hepatic carcinoma HepG2 and HepaRG cells. PMID: 25101946 Ref: Toxicogenomics directory of chemically exposed human hepatocytes. PMID: 25399406 |
Ref: Gene expression and pathway analysis of human hepatocellular carcinoma cells treated with cadmium. PMID: 26314618 |
Ref: CUL4B, NEDD4, and UGT1As involve in the TGF-beta signalling in hepatocellular carcinoma. PMID: 27236156 Ref: Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma. PMID: 27349315 |
Ref: The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma. PMID: 29983591 |